Events

Events

Upcoming Events
Past Events
Evaluation of aducanumab efficacy and safety in early Alzheimer’s disease Discussion at AD/PD
Mar 13, 2021
Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE Discussion at AD/PD
Mar 10, 2021
Biogen at the Cowen 41st Annual Health Care Conference
Mar 1, 2021
Aducanumab Phase 3 Topline Results at the AAN 2020 Science Highlights (encore virtual presentation replay)
Sep 23, 2020
Biogen at the Morgan Stanley Virtual Global Healthcare Conference (replay)
Sep 14, 2020
Biogen to Participate in SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum (replay)
Jun 23, 2020
Biogen at the 2020 World Medical Innovation Forum (replay)
May 11, 2020

Cautionary Statement and Acknowledgment

By proceeding further, you acknowledge and agree that your access to information contained in the “Medical and Scientific Conferences Presentations” section of the Biogen website:

  • Is provided for informational purposes for use by the investor community only; and
  • May include information about investigational compounds that have not been approved by the applicable regulatory authorities as safe and effective..

In addition, the scientific or medical presentations included in the “Medical and Scientific Conferences Presentations” section of the Biogen website may contain forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements may be accompanied by such words as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “possible,” “will” and other words and terms of similar meaning. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including those risks and uncertainties that are described in the Risk Factors section of Biogen’s most recent annual or quarterly report and in other reports Biogen has filed with the Securities and Exchange Commission (SEC) available at the SEC’s Internet (www.sec.gov). You should not place undue reliance on these statements or the scientific data presented. Forward-looking statements speak only as of the date of each presentation. Except as required by law, Biogen does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.